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The bioaccumulation of 20 pharmaceuticals in cockle (Cerastodema glaucum), noble pen shell (Pinna
nobilis), sea snail (Murex trunculus), golden grey mullet (Liza aurata) and black goby (Gobius niger) was
evaluated, considering their distribution throughout the Mar Menor lagoon and their variations in spring
and autumn 2010. The analytical procedure was adapted for the different matrices as being sensitive and
reproducible. Eighteen out of the 20 compounds analysed were found at low ng g1 in these species
throughout the lagoon. Hydrochlorothiazide and carbamazepine were detected in all species considered.
The bioaccumulation of pharmaceuticals was heterogeneous in the lagoon, with a higher number of
pharmaceuticals being detected in ﬁsh (18) than in wild molluscs (8), particularly in golden grey mullet
muscle (16). В-blockers and psychiatric drugs were preferentially bioccumulated in ﬁsh and hydro-
chlorothiazide was also conﬁrmed in caged clams. The higher detection frequency and concentrations
found in golden grey mullet suggested that mugilids could be used as an indicator of contamination by
pharmaceuticals in coastal areas. To the best of our knowledge, this is the ﬁrst study that shows data
about hydrochlorothiazide, levamisole and codeine in wild marine biota.
& 2016 Elsevier Inc. All rights reserved.1. Introduction
In recent years, the number of studies reporting the occurrence
of emerging contaminants in the marine environment has in-
creased as a consequence of anthropogenic activities worldwide,
the greater sensitivity of new analytical techniques and the rising
scientiﬁc interest in this subject. The pressure and impact of or-
ganic pollutants are greater in coastal areas than in the rest of the
marine environment, since these are where many human activities
are concentrated and direct and indirect discharges occur
(Sánchez-Bayo et al., 2011). Pharmaceuticals have frequently been
detected in the aquatic environment in the range of low ng L1 to
low μg L1 (Gros et al., 2012; Baker and Kasprzyk-Hordern, 2013;
Bayen et al., 2013, 2014) and are considered as pseudo-persistent
contaminants due to their degradation rate being lower than their
access rate (Daughton, 2002). In the marine environment, the site
conformation and hydrodynamic conditions largely determine the
spatial distribution of marine pharmaceutical concentrations (Ar-
pin-Pont et al., 2014) and they have predominantly been found in
seawater (Weigel et al., 2004; Pait et al., 2006; Su et al., 2007; Xu.et al., 2007; Wille et al., 2010; Yang et al., 2011; Zhao et al., 2011;
Zou et al., 2011; Zhang et al., 2012, 2013; Zheng et al., 2012; Bayen
et al., 2013; Rodríguez-Navas et al., 2013; Bayen et al., 2014; Xu
et al., 2014; Moreno-González et al., 2015), but less so in sediment
(Morales-Muñoz et al., 2005; Cueva-Mestanza et al., 2008; Land-
ford and Thomas, 2011; Pintado-Herrera et al., 2013, 2014; Stewart,
2013; Na et al., 2013; Moreno-González et al., 2015).
Due to the general hydrophility of pharmaceuticals, their
bioaccumulation potential can be considered irrelevant according
to the criteria for accumulation proposed by the OECD, namely
log Kow (octanol-water partition coefﬁcient)43 (OECD Guideline
315, 2008, Zenker et al., 2014). However, several authors reported
that compounds with log Kowo2 can show high bioaccumulation
(Le Bris and Pouliquen, 2004; Na et al., 2013), as has also been
observed for pharmaceuticals in freshwater ﬁsh (Connors et al.,
2013). In fact, the bioaccumulation of pharmaceuticals is not only
determined by chemical lipophilicity but recent studies have also
clearly pointed out other processes that participate in uptake and
bioaccumulation, such as effects on animal homoeostasis (Van der
Oost et al., 2003; Tierney et al., 2014; Daughton and Brooks, 2011;
Meredith-Williams et al., 2012; Franzelliti and Fabbri, 2014), in-
halational exposure as primary uptake (Du et al., 2014) and me-
tabolization by gills (Gómez et al., 2010, 2011). Environmental pH
can play an important role on their bioaccumulation since these
